Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease

被引:21
作者
Wang, Qing [1 ,2 ]
Chen, Gengsheng [1 ,2 ]
Schindler, Suzanne E. [2 ,3 ]
Christensen, Jon [2 ,3 ]
McKay, Nicole S. [2 ]
Liu, Jingxia [4 ]
Wang, Sicheng [5 ]
Sun, Zhexian [6 ]
Hassenstab, Jason [2 ,3 ]
Su, Yi [7 ,8 ]
Flores, Shaney [1 ]
Hornbeck, Russ [1 ]
Cash, Lisa [2 ]
Cruchaga, Carlos [3 ,9 ]
Fagan, Anne M. [2 ,3 ]
Tu, Zhude [1 ]
Morris, John C. [3 ]
Mintun, Mark A. [10 ]
Wang, Yong [1 ,5 ,6 ,11 ]
Benzinger, Tammie L. S. [1 ,2 ,12 ]
机构
[1] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Knight Alzheimer Dis Res Ctr, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[5] Washington Univ, Dept Elect & Syst Engn, Sch Med, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA
[7] Banner Alzheimers Inst, Phoenix, AZ USA
[8] Arizona Alzheimers Consortium, Phoenix, AZ USA
[9] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[10] Avid Radiopharmaceut, Philadelphia, PA USA
[11] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
[12] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA
来源
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION | 2022年 / 9卷 / 03期
关键词
HIPPOCAMPAL ATROPHY; DEMENTIA; PROTEIN;
D O I
10.1212/NXI.0000000000001152
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline. Methods Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of A beta 42, A beta 42/A beta 40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score). Results Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF A beta 42 or A beta 42/A beta 40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests. Discussion Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD. Classification of Evidence This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests.
引用
收藏
页数:11
相关论文
共 40 条
[1]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]   Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment [J].
Baldeiras, Ines ;
Santana, Isabel ;
Leitao, Maria Joao ;
Gens, Helena ;
Pascoal, Rui ;
Tabuas-Pereira, Miguel ;
Beato-Coelho, Jose ;
Duro, Diana ;
Almeida, Maria Rosario ;
Oliveira, Catarina Resende .
ALZHEIMERS RESEARCH & THERAPY, 2018, 10
[3]   MILD SENILE DEMENTIA OF THE ALZHEIMER TYPE .2. LONGITUDINAL ASSESSMENT [J].
BERG, L ;
MILLER, JP ;
STORANDT, M ;
DUCHEK, J ;
MORRIS, JC ;
RUBIN, EH ;
BURKE, WJ ;
COBEN, LA .
ANNALS OF NEUROLOGY, 1988, 23 (05) :477-484
[4]   Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a Comparative Overview [J].
Brosseron, Frederic ;
Krauthausen, Marius ;
Kummer, Markus ;
Heneka, Michael T. .
MOLECULAR NEUROBIOLOGY, 2014, 50 (02) :534-544
[5]   In-vivo measurement of activated microglia in dementia [J].
Cagnin, A ;
Brooks, DJ ;
Kennedy, AM ;
Gunn, RN ;
Myers, R ;
Turkheimer, FE ;
Jones, T ;
Banati, RB .
LANCET, 2001, 358 (9280) :461-467
[6]   Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases [J].
Alex Sik Chung Ching ;
Bertrand Kuhnast ;
Annelaure Damont ;
Dirk Roeda ;
Bertrand Tavitian ;
Frédéric Dollé .
Insights into Imaging, 2012, 3 (1) :111-119
[7]   Inflammation and Microglia Actions in Alzheimer's Disease [J].
Combs, Colin K. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2009, 4 (04) :380-388
[8]   Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease [J].
Dani, Melanie ;
Wood, Melanie ;
Mizoguchi, Ruth ;
Fan, Zhen ;
Walker, Zuzana ;
Morgan, Richard ;
Hinz, Rainer ;
Biju, Maya ;
Kuruvilla, Tarun ;
Brooks, David J. ;
Edison, Paul .
BRAIN, 2018, 141 :2740-2754
[9]   The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline [J].
Donohue, Michael C. ;
Sperling, Reisa A. ;
Salmon, David P. ;
Rentz, Dorene M. ;
Raman, Rema ;
Thomas, Ronald G. ;
Weiner, Michael ;
Aisen, Paul S. .
JAMA NEUROLOGY, 2014, 71 (08) :961-970
[10]   Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study [J].
Edison, Paul ;
Archer, Hilary A. ;
Gerhard, Alexander ;
Hinz, Rainer ;
Pavese, Nicola ;
Turkheimer, Federico E. ;
Hammers, Alexander ;
Tai, Yen Fong ;
Fox, Nick ;
Kennedy, Angus ;
Rossor, Martin ;
Brooks, David J. .
NEUROBIOLOGY OF DISEASE, 2008, 32 (03) :412-419